Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Phthalazines | 1 | 2016 | 64 | 0.450 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2016 | 132 | 0.410 |
Why?
|
| Piperazines | 1 | 2016 | 381 | 0.390 |
Why?
|
| Ovarian Neoplasms | 1 | 2016 | 586 | 0.300 |
Why?
|
| Systemic Inflammatory Response Syndrome | 2 | 2022 | 96 | 0.220 |
Why?
|
| United States Indian Health Service | 1 | 2024 | 45 | 0.210 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 2197 | 0.210 |
Why?
|
| Gonorrhea | 1 | 2024 | 65 | 0.200 |
Why?
|
| International Classification of Diseases | 1 | 2024 | 147 | 0.200 |
Why?
|
| Chlamydia Infections | 1 | 2024 | 81 | 0.200 |
Why?
|
| Exanthema | 1 | 2022 | 84 | 0.180 |
Why?
|
| Connective Tissue Diseases | 1 | 2022 | 84 | 0.180 |
Why?
|
| HLA-A Antigens | 2 | 2008 | 52 | 0.140 |
Why?
|
| Sexual and Gender Minorities | 1 | 2022 | 251 | 0.140 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2008 | 917 | 0.130 |
Why?
|
| HIV Infections | 4 | 2022 | 3154 | 0.130 |
Why?
|
| Antigens, Fungal | 1 | 2016 | 28 | 0.120 |
Why?
|
| Cryptococcus | 1 | 2016 | 16 | 0.120 |
Why?
|
| Point-of-Care Testing | 1 | 2016 | 35 | 0.120 |
Why?
|
| Cryptococcosis | 1 | 2016 | 31 | 0.120 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2016 | 130 | 0.110 |
Why?
|
| Stem Cell Factor | 1 | 2013 | 17 | 0.100 |
Why?
|
| United States | 4 | 2024 | 15988 | 0.100 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2013 | 53 | 0.100 |
Why?
|
| Neurofibroma, Plexiform | 1 | 2012 | 12 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2013 | 72 | 0.090 |
Why?
|
| Cyclic AMP | 1 | 2013 | 209 | 0.090 |
Why?
|
| Neurofibromatosis 1 | 1 | 2012 | 54 | 0.090 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2013 | 75 | 0.090 |
Why?
|
| Testicular Neoplasms | 1 | 2013 | 113 | 0.090 |
Why?
|
| HIV-1 | 2 | 2007 | 896 | 0.080 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 1054 | 0.080 |
Why?
|
| Genes, T-Cell Receptor beta | 1 | 2008 | 23 | 0.070 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 2008 | 16 | 0.070 |
Why?
|
| Bone Density | 1 | 2012 | 482 | 0.070 |
Why?
|
| Cytomegalovirus | 1 | 2008 | 168 | 0.070 |
Why?
|
| Herpesvirus 4, Human | 1 | 2008 | 176 | 0.070 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2008 | 175 | 0.070 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2008 | 101 | 0.060 |
Why?
|
| Child | 3 | 2022 | 22657 | 0.060 |
Why?
|
| Cytomegalovirus Infections | 1 | 2008 | 206 | 0.060 |
Why?
|
| Enterobacteriaceae | 1 | 2006 | 43 | 0.060 |
Why?
|
| Bacterial Translocation | 1 | 2006 | 52 | 0.060 |
Why?
|
| Humans | 12 | 2024 | 144957 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2024 | 1990 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 2147 | 0.060 |
Why?
|
| Immune System | 1 | 2006 | 179 | 0.060 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2008 | 668 | 0.050 |
Why?
|
| Virus Replication | 1 | 2007 | 529 | 0.050 |
Why?
|
| Homosexuality, Male | 1 | 2022 | 222 | 0.040 |
Why?
|
| Minority Groups | 1 | 2022 | 282 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2013 | 5233 | 0.040 |
Why?
|
| Female | 4 | 2024 | 78376 | 0.030 |
Why?
|
| Ethiopia | 1 | 2016 | 44 | 0.030 |
Why?
|
| Meningitis, Cryptococcal | 1 | 2016 | 34 | 0.030 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2016 | 277 | 0.030 |
Why?
|
| Male | 5 | 2024 | 72406 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2008 | 2157 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 1695 | 0.030 |
Why?
|
| 3',5'-Cyclic-GMP Phosphodiesterases | 1 | 2013 | 17 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2008 | 2931 | 0.020 |
Why?
|
| Young Adult | 2 | 2024 | 14126 | 0.020 |
Why?
|
| Femur Neck | 1 | 2012 | 62 | 0.020 |
Why?
|
| Logistic Models | 1 | 2016 | 2119 | 0.020 |
Why?
|
| Adult | 3 | 2024 | 40506 | 0.020 |
Why?
|
| Lumbar Vertebrae | 1 | 2012 | 252 | 0.020 |
Why?
|
| Adolescent | 2 | 2024 | 22453 | 0.020 |
Why?
|
| HLA-A2 Antigen | 1 | 2008 | 35 | 0.020 |
Why?
|
| CD8 Antigens | 1 | 2008 | 72 | 0.020 |
Why?
|
| Genotype | 1 | 2013 | 1835 | 0.020 |
Why?
|
| CD57 Antigens | 1 | 2007 | 18 | 0.020 |
Why?
|
| HLA-B27 Antigen | 1 | 2007 | 16 | 0.020 |
Why?
|
| Gene Products, gag | 1 | 2007 | 38 | 0.020 |
Why?
|
| Lymphocyte Count | 1 | 2007 | 164 | 0.020 |
Why?
|
| Cercocebus atys | 1 | 2006 | 6 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2013 | 1407 | 0.020 |
Why?
|
| Simian Immunodeficiency Virus | 1 | 2006 | 92 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 2006 | 191 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2024 | 17101 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2016 | 5965 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 3550 | 0.010 |
Why?
|
| Cellular Senescence | 1 | 2007 | 226 | 0.010 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2006 | 278 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 5872 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2008 | 1173 | 0.010 |
Why?
|
| Feces | 1 | 2006 | 513 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2006 | 863 | 0.010 |
Why?
|
| Middle Aged | 1 | 2024 | 35928 | 0.010 |
Why?
|
| Risk Factors | 1 | 2016 | 10792 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2006 | 1813 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2007 | 2499 | 0.010 |
Why?
|
| Anti-HIV Agents | 1 | 2006 | 888 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2012 | 11799 | 0.010 |
Why?
|
| Animals | 1 | 2006 | 38109 | 0.000 |
Why?
|